Boston Scientific Corp. closed 4.20% short of its 52-week high of $107.17, which the company achieved on February 5th.

Boston Scientific disclosed executive pay for 2024 and reported a rebound in its median employee's pay after a large drop the ...

Boston Scientific (BSX) closed the latest trading day at $102.67, indicating a +1.97% change from the previous session's end. The stock outpaced the S&P 500's daily gain of 1.77%. On the other hand, ...

Madison Investment Advisors LLC purchased a new position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during ...

Boston Scientific BSX has witnessed strong momentum in the past year. Shares of the company have risen 42.4% compared with 8.5% growth of the industry during the same time frame. The S&P 500 Composite ...

The stock's fall snapped a two-day winning streak.

Boston Scientific has shown high revenue and EPS growth rates in recent years. See why I recommend a hold rating for BSX ...

Boston Scientific (NYSE: BSX) is buying into the business of acquisitions. The Marlborough medical device firm has announced its second acquisition thus far in 2025. Boston Scientific Corp. has ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire SoniVie, a privately held medical device company that has developed the Tivus Intravascular Ultrasound System.

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the November 21st expiration. One of the key inputs that goes into the price an option buyer is willing ...

Bearish flow noted in Boston Scientific (BSX) with 5,153 puts trading, or 4x expected. Most active are Mar-25 100 puts and Mar-25 103 calls, with total volume in those strikes near 3,300 contracts.